Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Buying

Goldline Pharmaceutical Promoter Buying

Promoter Swapan Khandelwal increased his stake in Goldline Pharmaceutical Limited by 0.81% through an open market acquisition of 78,000 shares.

Source

BSE filing, BSE: 544759. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Goldline Pharmaceutical Ltd: key numbers

Share price
₹30.50
Market cap
₹29.28 Cr
Revenue (annual)
₹31.20 Cr
Net profit (annual)
₹4.12 Cr
P/E (TTM)
7.1×Sector 46.1×
Promoter holding
59.54%
FII holding
0.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Goldline Pharmaceutical Ltd

All →

Other promoter buying announcements

All →
10:37 IST BSE
Promoter BuyingQuint Digital Ltd QUINT

Quint Digital Promoter Buying

Promoter group of Raghav Bahl acquired 2,932,138 non-voting CCPS of Quint Digital in open market by Oct 23, 2026. Diluted promoter holding rose from 48.27% to 52.84%.

Promoter stake change
+4.57%